Contact PI/Project LeaderECKSTEIN, MIGUEL PATRICIO
Awardee OrganizationUNIVERSITY OF CALIFORNIA SANTA BARBARA
Description
Abstract Text
Early detection through screening mammography has decreased death rates from breast cancer. There are
approximately 39 million mammogram procedures conducted each year in the US. However, there are still
alarmingly high error rates in radiological interpretations, with missed cancer rates ranging from 10-18 percent
and false positive rates as high as 67% over a 10-year period. To reduce error rates, digital breast
tomosynthesis, a new 3D imaging technology intended to make cancers more visible to the radiologist, is
rapidly being introduced throughout clinics in the US. The widespread adoption of new 3D technologies has
dramatically increased the data volume that radiologists must scrutinize and has fundamentally altered how
they search, relying on vision away from where they are fixating (peripheral vision), eye movements, and
image (slice) scrolls to find potential disease. Yet, we are missing a theoretical and empirical understanding of
how radiologists might best search through 3D clinical images to maximize target detection while maintaining
reasonable reading times. Furthermore, what metrics to use to optimize image processing and acquisition
parameters to maximize radiologists’ performance with the new 3D technologies? The last 30 years of the field
of medical imaging have been shaped by task-based image quality metrics based on ideal and model
observers that mimic human performance. And yet, these often omit human bottlenecks of peripheral visual
processing and do not work with 3D search with clinical images or phantoms. In this context, the overall goal of
the current proposal is to combine recent Deep Neural Network developments and biologically-plausible
models of human-foveated vision to create a model that learns about anatomy and optimally (performance
maximizing) programs eye movements and scrolls to find lesions in digital phantoms and clinical images
(foveated search DNN, FS-DNN). If successful, the FS-DNN could be used to evaluate in what way a
particular radiologist is not adequately examining the 3D clinical, estimate the accuracy costs of the
scroll/search inefficiency, and determine how they might improve. The project will implement learning
protocols based on FS-DNN/human comparisons and assess their impact on improving diagnostic accuracy. If
successful, the FS-DNN could be a new powerful metric of image quality for 3D search that, unlike previous
models, can be applied to phantoms and clinical images. A collaboration with the Food and Drug
Administration (FDA) aims at integrating the developed FS-DNN model with the FDA Virtual Imaging Clinical
Trial for Regulatory Evaluation (VICTRE) pipeline that is made available to academic researchers and industry
technology developers. Together, these advances can potentially help reduce radiological errors with digital
breast tomosynthesis and also help evaluate and optimize new technologies. Although the proposed work is
developed for breast cancer and DBT, the approach, framework and concepts investigated are potentially
applicable to other areas of 3D medical images in radiology.
Public Health Relevance Statement
3D imaging is rapidly replacing 2D planar images in radiology. We aim to create a model
with radiologist-like vision that learns to best search and scroll through 3D volumes. The
model can be used to identify inefficiencies in radiologists' search/scroll strategies and
mitigate search errors, and as a tool to evaluate and optimize the quality of 3D medical
imaging technology.
NIH Spending Category
No NIH Spending Category available.
Project Terms
3-DimensionalAdoptedAdoptionAnatomyArchitectureAreaBackBehaviorBenignBindingBreast MicrocalcificationClinicClinicalClinical TrialsCollaborationsDataDatabasesDeath RateDetectionDevelopmentDigital Breast TomosynthesisDiseaseEarly DiagnosisEvaluationEye MovementsFeedbackGoalsHealth systemHumanImageImaging technologyIndustryLearningLesionMalignant - descriptorMalignant Breast NeoplasmMalignant NeoplasmsMammographic screeningMammographyMeasuresMedical ImagingModelingModernizationNoisePathologyPatternPennsylvaniaPerformancePeripheralProceduresProtocols documentationPsychological reinforcementRadiology SpecialtyReadingResearch PersonnelScanningShapesSignal TransductionSliceSourceTechniquesTechnologyThree Dimensional Medical ImagingThree-Dimensional ImageThree-Dimensional ImagingTrainingUnited States Food and Drug AdministrationUniversitiesVisionWorkclinical imagingcostdeep neural networkdiagnostic accuracydigitalgazehuman modelimage processingimprovednew technologypre-trained transformerprogramsradiation mitigationradiologistsample fixationspatiotemporaltheoriestoolvirtual clinical trialvirtual imagingvision sciencevisual processingvisual search
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
094878394
UEI
G9QBQDH39DF4
Project Start Date
15-September-2018
Project End Date
31-May-2028
Budget Start Date
01-September-2024
Budget End Date
31-May-2025
Project Funding Information for 2024
Total Funding
$386,220
Direct Costs
$265,060
Indirect Costs
$121,160
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$386,220
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 2R01EB026427-05A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2R01EB026427-05A1
Patents
No Patents information available for 2R01EB026427-05A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2R01EB026427-05A1
Clinical Studies
No Clinical Studies information available for 2R01EB026427-05A1
News and More
Related News Releases
No news release information available for 2R01EB026427-05A1
History
No Historical information available for 2R01EB026427-05A1
Similar Projects
No Similar Projects information available for 2R01EB026427-05A1